Comparison of In‐Office and General Anesthesia Biopsies for Oropharyngeal Squamous Cell Carcinoma in a Public Healthcare System

Authors:

Abstract
Background: We compared treatment delays, costs, and management impact between oropharyngeal squamous cell carcinoma (OPSCC) patients undergoing in‐office versus general anesthesia panendoscopy‐guided biopsies in two large tertiary centers in a public healthcare system. Methods: All OPSCC patients included were treated between 2010 and 2024 with either curative radiation alone or chemoradiation. Results: Demographic and tumor characteristics were comparable, except for smaller tumors in the panendoscopy group ( n = 36) compared to the in‐office group ( n = 37) (mean size; 29.4 mm vs. 36.6 mm, respectively; difference −7.2 mm [95% CI, −11.3 to −3.1]). The panendoscopy group experienced substantially longer treatment initiation delays (mean days; 70.1 days vs. 44.5 days; difference 25.7 days [95% CI 13.0 to 38.2]). No additional synchronous tumors were detected through panendoscopy. Panendoscopy incurred a mean additional cost of 2025CAD $3886. Conclusions: Panendoscopy for OPSCC prolongs treatment initiation, incurs additional expenses, and provides no incremental synchronous tumor detection. When clinically feasible, in‐office biopsies should be preferred.
Funding Information
  • Université de Montréal

This publication has 14 references indexed in Scilit: